November Update:

Kent's tumour is responding to the combination of daily Etoposide (VP-6) and bi-weekly Avastin chemo treatments. In comparisons of the MRI from November 5 to the MRI from November 26 shows significant shrinkage in the tumour mass in the corpus collosum area. The Avastin is stopping the blood supply to the tumour and the Etoposide is killing the tumour cells. This is great news considering that Kent had only been receiving the treatment for 20 days between the two MRI's.